Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 2
This trial is looking at giving acalabrutinib with chemotherapy for Diffuse Large B Cell Lymphoma (DLBCL).
This trial is for people with DLBCL that haven’t had treatment and are well enough to have chemotherapy with the aim to cure their cancer.
Cancer Research UK supports this trial.
Recruitment start: 19 October 2021
Recruitment end: 30 June 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Davies
AstraZeneca
Cancer Research UK
University Hospital Southampton NHS Foundation Trust
National Institute for Health Research (NIHR)
Acerta Pharma BV
This is Cancer Research UK trial number CRUKE/19/017.
Last reviewed: 29 Jun 2025
CRUK internal database number: 17188
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
